logo-loader
viewFluroTech

FluroTech receives licence from Health Canada

FluroTech (CVE:TEST: OTCQB:FLURF) President and CEO Danny Dalla-Longa sat down with Steve Darling from Proactive at the MJ Micro Conference to discuss the cannabis testing company receiving their licence from Health Canada. Dall-Longa talks about why they needed that licence.

Dalla-Longa also told Proactive about their move in the US market and what areas he expects growth coming from.

Quick facts: FluroTech

Price: 0.2 CAD

TSX-V:TEST
Market: TSX-V
Market Cap: $10.85 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn reveals its drug inhibits colon carcinoma metastases...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive its flagship drug leronlimab inhibited a human colon carcinoma cell line metastases to liver and lung in a well-accepted mouse model. Pourhassan says the company plans to file an IND for expanded access for a Phase 2 basket...

10 hours, 44 minutes ago

2 min read